World Health Organization (WHO)
#AskWHO Tackling non-communicable diseases
Related Articles
Permanente Live webinar — Finding success in value-based care
Register As U.S. health care shifts toward value-based models, the question isn’t if your organization will transition — it’s when and how to do it successfully. Although fee-for-service continues to…
Post-VISION Real World Experience in the US: How is PSMA RLT Being Used? “Presentation” – Matthew Rettig
At the 2025 UCSF-UCLA PSMA Conference, Matthew Rettig discusses real-world PSMA radioligand therapy usage in the VA healthcare system. He highlights VA patients are older…
Establishment and long-term expansion of adult hepatobiliary organoids co-cultured with liver endothelial cells
The liver has a unique ability to regenerate in response to injury or disease with hepatocytes and biliary epithelial cells (BECs) driving the regenerative response.…
Complex Cases in Atopic Dermatitis and Hair Loss, with Tiffany Mayo, MD
In this Q&A interview at RAD 2025, Tiffany Mayo, MD, highlights the biggest takeaways from her talk on complex cases in atopic dermatitis and hair…
Here are the recommendations to come out of the 2025 AMA meeting
The American Medical Association’s annual meeting grappled with myriad ssues facing healthcare providers this year.
New classification system offers ‘clear method’ for assessing ultra-processed foods
ORLANDO — A new system for classifying processed foods may provide a more accurate assessment of their health impacts, according to data presented at the…
Pharmalittle: We’re reading about Trump and drug prices, BioNTech buying Curevac, and more
The Trump administration had said it would disclose by Wednesday the target prices for drugs, but pharma companies are still waiting
